Literature DB >> 6628839

An international study of agglutinins to Eubacterium, Peptostreptococcus and Coprococcus species in Crohn's disease, ulcerative colitis and control subjects.

F Wensinck, J P van de Merwe, J F Mayberry.   

Abstract

The world-wide occurrence of agglutinating antibodies to four coccoid anaerobes belonging to Eubacterium, Peptostreptococcus and Coprococcus spp. was investigated in 937 coded sera from patients suffering from Crohn's disease, ulcerative colitis, various other diseases and from healthy controls. Positive results were found in 59% of patients with Crohn's disease, 29% of patients with ulcerative colitis, and 8% of both diseased and healthy control subjects. Patients with Crohn's disease of the colon had more positive tests (67%) than patients with disease confined to the small bowel (46%). The results show that agglutinating antibodies to the coccoid anaerobes occur more frequently in patients with Crohn's disease than in other subjects in widely varying geographic regions.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6628839     DOI: 10.1159/000198931

Source DB:  PubMed          Journal:  Digestion        ISSN: 0012-2823            Impact factor:   3.216


  11 in total

1.  A limiting-dilution analysis of activated circulating B cells in Crohn's disease.

Authors:  M Boirivant; F Quintieri; O Pugliese; G Famularo; S Fais; F Pallone
Journal:  J Clin Immunol       Date:  1990-03       Impact factor: 8.317

2.  Antibiotic Treatment Induces Long-lasting Changes in the Fecal Microbiota that Protect Against Colitis.

Authors:  Naomi L Ward; Caleb D Phillips; Deanna D Nguyen; Nanda Kumar N Shanmugam; Yan Song; Richard Hodin; Hai Ning Shi; Bobby J Cherayil; Allan M Goldstein
Journal:  Inflamm Bowel Dis       Date:  2016-10       Impact factor: 5.325

3.  Antibody response to anaerobic coccoid rods in Crohn's disease.

Authors:  K Bull; N Matthews; J Rhodes
Journal:  J Clin Pathol       Date:  1986-10       Impact factor: 3.411

4.  Agglutinins to bacteria as a discriminatory test in Crohn's disease.

Authors:  G F McCoy; T G Parks; W A Hanna; F Wensinck
Journal:  Ir J Med Sci       Date:  1984-04       Impact factor: 1.568

5.  Culturing and extraction of Coprococcus comes, absorption of serumagglutinins by soluble fractions and relation between agglutinins and antibodies in sera of patients with Crohn's disease.

Authors:  M P Hazenberg; A M Pennock-Schröder; J P van de Merwe
Journal:  Med Microbiol Immunol       Date:  1986       Impact factor: 3.402

6.  Induction in rats of serum agglutinins to Eubacterium, Peptostreptococcus and Coprococcus species by the faecal flora from patients with Crohn's disease and healthy subjects.

Authors:  M P Hazenberg; J P Van de Merwe; L M Custers-Van Lieshout; A M Pennock-Schröder
Journal:  J Hyg (Lond)       Date:  1984-10

Review 7.  The human faecal flora and Crohn's disease.

Authors:  J P van de Merwe
Journal:  Antonie Van Leeuwenhoek       Date:  1984       Impact factor: 2.271

8.  Dysbiosis, inflammation, and response to treatment: a longitudinal study of pediatric subjects with newly diagnosed inflammatory bowel disease.

Authors:  Kelly A Shaw; Madeline Bertha; Tatyana Hofmekler; Pankaj Chopra; Tommi Vatanen; Abhiram Srivatsa; Jarod Prince; Archana Kumar; Cary Sauer; Michael E Zwick; Glen A Satten; Aleksandar D Kostic; Jennifer G Mulle; Ramnik J Xavier; Subra Kugathasan
Journal:  Genome Med       Date:  2016-07-13       Impact factor: 11.117

9.  Gut microbiomes of Malawian twin pairs discordant for kwashiorkor.

Authors:  Michelle I Smith; Tanya Yatsunenko; Mark J Manary; Indi Trehan; Rajhab Mkakosya; Jiye Cheng; Andrew L Kau; Stephen S Rich; Patrick Concannon; Josyf C Mychaleckyj; Jie Liu; Eric Houpt; Jia V Li; Elaine Holmes; Jeremy Nicholson; Dan Knights; Luke K Ursell; Rob Knight; Jeffrey I Gordon
Journal:  Science       Date:  2013-01-30       Impact factor: 47.728

10.  Zinc inhibits lethal inflammatory shock by preventing microbe-induced interferon signature in intestinal epithelium.

Authors:  Jolien Souffriau; Steven Timmermans; Tineke Vanderhaeghen; Charlotte Wallaeys; Kelly Van Looveren; Lindsy Aelbrecht; Sylviane Dewaele; Jolien Vandewalle; Evy Goossens; Serge Verbanck; Filip Boyen; Melanie Eggermont; Lindsey De Commer; Riet De Rycke; Michiel De Bruyne; Raul Tito; Marlies Ballegeer; Sofie Vandevyver; Tiago Velho; Luis Ferreira Moita; Tino Hochepied; Karolien De Bosscher; Jeroen Raes; Filip Van Immerseel; Rudi Beyaert; Claude Libert
Journal:  EMBO Mol Med       Date:  2020-09-11       Impact factor: 12.137

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.